Today's Daily Dose brings you news about the clinical hold imposed by the FDA on Larimar's CTI-1601 clinical program; Pieris Pharma teaming up with Genentech; the upcoming regulatory catalyst of Provention Bio; the possible delay in Travere seeking approval for Sparsentan; and the approval of Taiwan Liposome's Liposomal Amphotericin B injection in India to fight the growing cases of black fungus.
from RTT - Top Story https://ift.tt/2SugS77
via IFTTT
from RTT - Top Story https://ift.tt/2SugS77
via IFTTT
Comments
Post a Comment